| 000 | 01679 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515145114.0 | ||
| 264 | 0 | _c20090206 | |
| 008 | 200902s 0 0 eng d | ||
| 022 | _a1756-9966 | ||
| 024 | 7 |
_a10.1186/1756-9966-27-60 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Shiwu | |
| 245 | 0 | 0 |
_aThalidomide influences growth and vasculogenic mimicry channel formation in melanoma. _h[electronic resource] |
| 260 |
_bJournal of experimental & clinical cancer research : CR _cNov 2008 |
||
| 300 |
_a60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xmetabolism |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xmetabolism |
| 650 | 0 | 4 | _aMatrix Metalloproteinase Inhibitors |
| 650 | 0 | 4 |
_aMelanoma _xblood supply |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMicrovessels _xmetabolism |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aProliferating Cell Nuclear Antigen _xmetabolism |
| 650 | 0 | 4 |
_aThalidomide _xadministration & dosage |
| 650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xantagonists & inhibitors |
| 700 | 1 | _aLi, Man | |
| 700 | 1 | _aGu, Yanjun | |
| 700 | 1 | _aLiu, Zhiyong | |
| 700 | 1 | _aXu, Shaoyan | |
| 700 | 1 | _aCui, Yanfeng | |
| 700 | 1 | _aSun, Baocun | |
| 773 | 0 |
_tJournal of experimental & clinical cancer research : CR _gvol. 27 _gp. 60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1756-9966-27-60 _zAvailable from publisher's website |
| 999 |
_c18444990 _d18444990 |
||